Bioventus (BVS) Exchange Rate Effect (2020 - 2026)
Bioventus' (BVS) quarterly Exchange Rate Effect came in at -$370000.0 in Q2 2026, down 283.17% on a YoY basis from $202000.0 in Q2 2025, and up 39.14% quarter-over-quarter from -$608000.0 in Q1 2026.
Powered by 
Analysis
Bioventus (BVS) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Bioventus (BVS) has reported Exchange Rate Effect for 7 consecutive years, with -$370000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Exchange Rate Effect fell 283.17% year-over-year to -$370000.0; the trailing twelve-month figure through Jun 2026 stood at -$1.2 million (down 28.39% YoY), and the FY2025 full-year result was $371000.0, up 114.49% from the prior year.
- Exchange Rate Effect grew to -$370000.0 in Q2 2026 per BVS's latest filing, from -$608000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.1 million in Q4 2022 and bottomed at -$2.1 million in Q4 2024.
- Historically, Exchange Rate Effect has averaged -$112055.6 across 5 years, with a median of -$146500.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Exchange Rate Effect soared 749.3% in 2023, then tumbled 660.6% in 2024.
- Over 5 years, Exchange Rate Effect stood at $1.1 million in 2022, then sank by 65.02% to $368000.0 in 2023, then sank by 660.6% to -$2.1 million in 2024, then surged by 106.45% to $133000.0 in 2025, then plunged by 378.2% to -$370000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$370000.0, -$608000.0, and $133000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 4.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 7.10 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -89.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -14.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 3.80 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -4.90 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -2.30 Mn |
| 10 | Bioventus | 923.70 Mn | 894.24 Mn | 105.67 Mn | -370,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | -370,000.00 |
| Mar 28, 2026 | -608,000.00 |
| Dec 31, 2025 | 133,000.00 |
| Sep 27, 2025 | -394,000.00 |
| Jun 28, 2025 | 202,000.00 |
| Mar 29, 2025 | 430,000.00 |
| Dec 31, 2024 | -2.06 Mn |
| Sep 28, 2024 | 466,000.00 |
| Jun 29, 2024 | -419,000.00 |
| Mar 30, 2024 | -544,000.00 |
| Dec 31, 2023 | 368,000.00 |
| Sep 30, 2023 | -440,000.00 |
| Jul 1, 2023 | 240,000.00 |
| Apr 1, 2023 | 461,000.00 |
| Dec 31, 2022 | 1.05 Mn |
| Oct 1, 2022 | -238,000.00 |
| Jul 2, 2022 | -222,000.00 |
| Apr 2, 2022 | -71,000.00 |
| Dec 31, 2021 | 149,000.00 |
| Oct 2, 2021 | -206,000.00 |